找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Gene Therapy and Cell Therapy Through the Liver; Current Aspects and Shuji Terai,Takeshi Suda Book 2016 Springer Japan 2016 CPC Isolator.a

[復(fù)制鏈接]
查看: 16670|回復(fù): 47
樓主
發(fā)表于 2025-3-21 16:44:43 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Gene Therapy and Cell Therapy Through the Liver
副標(biāo)題Current Aspects and
編輯Shuji Terai,Takeshi Suda
視頻videohttp://file.papertrans.cn/382/381971/381971.mp4
概述Provides extensive information for examining the wide varieties of pathological conditions both inside and outside the liver.Focuses on cell therapy, gene therapy, and legal regulation of the applicat
圖書封面Titlebook: Gene Therapy and Cell Therapy Through the Liver; Current Aspects and  Shuji Terai,Takeshi Suda Book 2016 Springer Japan 2016 CPC Isolator.a
描述.This book reports the recent progress in gene and cell therapy through the liver and aims to facilitate a comprehensive understanding of the current aspects and future prospects from basic research to clinical therapies. Edited by pioneering researchers, this volume presents extensive information to principal investigators, researchers, postdocs and clinicians for examining the wide varieties of pathological conditions both inside and outside the liver..Providing not only the basic and clinical aspects of therapy, this volume is special in that it focuses on the administrative and regulatory difficulties of actual clinical application and legal regulations in different parts of the globe. By indicating the advantages and limitations of the most promising gene and cell therapies targeting the liver, this book will inspire readers to develop a feasible treatment in the next generation.
出版日期Book 2016
關(guān)鍵詞CPC Isolator; adeno-associated virus (AAV); immunotherapy; legal regulation; liver fibrosis; regeneration
版次1
doihttps://doi.org/10.1007/978-4-431-55666-4
isbn_softcover978-4-431-56251-1
isbn_ebook978-4-431-55666-4
copyrightSpringer Japan 2016
The information of publication is updating

書目名稱Gene Therapy and Cell Therapy Through the Liver影響因子(影響力)




書目名稱Gene Therapy and Cell Therapy Through the Liver影響因子(影響力)學(xué)科排名




書目名稱Gene Therapy and Cell Therapy Through the Liver網(wǎng)絡(luò)公開度




書目名稱Gene Therapy and Cell Therapy Through the Liver網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Gene Therapy and Cell Therapy Through the Liver被引頻次




書目名稱Gene Therapy and Cell Therapy Through the Liver被引頻次學(xué)科排名




書目名稱Gene Therapy and Cell Therapy Through the Liver年度引用




書目名稱Gene Therapy and Cell Therapy Through the Liver年度引用學(xué)科排名




書目名稱Gene Therapy and Cell Therapy Through the Liver讀者反饋




書目名稱Gene Therapy and Cell Therapy Through the Liver讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:41:06 | 只看該作者
Macrophage Therapy for Liver Fibrosis and Regenerationjury both the resident macrophages and circulating monocytes influence both liver regeneration and liver fibrosis. Kupffer cells can stimulate hepatocyte proliferation via the secretion of IL-6; macrophages stimulate a ductular proliferation via TWEAK secretion and also secrete Wnts which stimulate
板凳
發(fā)表于 2025-3-22 01:04:47 | 只看該作者
地板
發(fā)表于 2025-3-22 06:39:56 | 只看該作者
Novel Immunotherapy Using Liver-Derived Natural Killer Cells for Preventing Hepatocellular Carcinomaants. However, no prevention or treatment exists for HCC recurrence after liver transplantation. Here, we describe an adoptive immunotherapy approach that uses natural killer (NK) cells derived from both living and deceased donor liver graft perfusates. Liver NK cells exhibited the vigorous cytotoxi
5#
發(fā)表于 2025-3-22 12:46:19 | 只看該作者
6#
發(fā)表于 2025-3-22 16:34:12 | 只看該作者
7#
發(fā)表于 2025-3-22 19:10:07 | 只看該作者
Potential Usage of Human Artificial Chromosome for Regenerative Medicineneered creation) or a “bottom-up approach” (de novo creation). HACs with one or more acceptor sites exhibit several characteristics required by an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci plus their regulatory elements, thus allow
8#
發(fā)表于 2025-3-22 21:28:06 | 只看該作者
Image-Guided Hydrodynamic Gene Delivery to the Liver: Toward Clinical Applicationsn its cells. Conventional therapeutic methods are often insufficient or unavailable to manage genetic diseases in the liver; therefore, more efficient strategies are urgently needed. Gene therapy emerged as novel method of treatment relying on liver-directed transfer of a gene-coding sequence to pro
9#
發(fā)表于 2025-3-23 03:52:22 | 只看該作者
10#
發(fā)表于 2025-3-23 06:48:51 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 15:19
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
增城市| 色达县| 大关县| 禄劝| 延吉市| 霍林郭勒市| 新建县| 琼结县| 安康市| 安多县| 洛隆县| 左贡县| 南陵县| 营口市| 和硕县| 鲁甸县| 兰坪| 达孜县| 北海市| 昔阳县| 湘潭市| 读书| 淮阳县| 阳原县| 上栗县| 邵东县| 高雄市| 咸宁市| 治多县| 南安市| 三台县| 两当县| 九台市| 湘潭市| 蕲春县| 鲁山县| 鄂州市| 广安市| 鄄城县| 昭平县| 泸西县|